Printer Friendly Version

Send to a Friend

Boston University Medical Center has received final approval from the Boston Redevelopment Authority for its 410,000-sf BioSquare Phase II project in Boston. Funded by a $128 million grant from the National Institute of Allergy and Infectious Diseases, the project will include a BSL-4 research laboratory and a 1,400-space parking garage. The facility will be part of a national network of laboratories dedicated to countering bioterror agents by developing drugs, treatments, and vaccines.